Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125877151 | 12587715 | 1 | I | 2012 | 20160713 | 20160725 | 20160725 | EXP | US-GLAXOSMITHKLINE-US2016100720 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125877151 | 12587715 | 1 | PS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | UNKNOWN | 204275 | 1 | DF | INHALATION POWDER | QD | |||||
| 125877151 | 12587715 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID 250/50 MCG | Y | UNKNOWN | 0 | 1 | DF | INHALATION POWDER | BID | ||||
| 125877151 | 12587715 | 3 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 100/50 MCG | Y | 0 | INHALATION POWDER | |||||||||
| 125877151 | 12587715 | 4 | SS | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | UNK | Y | UNKNOWN | 0 | NASAL SPRAY | |||||||
| 125877151 | 12587715 | 5 | SS | FLONASE | FLUTICASONE PROPIONATE | 1 | Y | 0 | NASAL SPRAY | ||||||||||
| 125877151 | 12587715 | 6 | SS | VERAMYST | FLUTICASONE FUROATE | 1 | Nasal | UNK | Y | UNKNOWN | 0 | NASAL SPRAY | |||||||
| 125877151 | 12587715 | 7 | SS | VERAMYST | FLUTICASONE FUROATE | 1 | Y | 0 | NASAL SPRAY | ||||||||||
| 125877151 | 12587715 | 8 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | Y | UNKNOWN | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125877151 | 12587715 | 1 | Asthma |
| 125877151 | 12587715 | 2 | Asthma |
| 125877151 | 12587715 | 4 | Multiple allergies |
| 125877151 | 12587715 | 5 | Chronic sinusitis |
| 125877151 | 12587715 | 6 | Multiple allergies |
| 125877151 | 12587715 | 7 | Chronic sinusitis |
| 125877151 | 12587715 | 8 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125877151 | 12587715 | Blood glucose increased | |
| 125877151 | 12587715 | Chronic sinusitis | |
| 125877151 | 12587715 | Drug dose omission | |
| 125877151 | 12587715 | Drug ineffective | |
| 125877151 | 12587715 | Dysphonia | |
| 125877151 | 12587715 | Hypoaesthesia | |
| 125877151 | 12587715 | Malaise | |
| 125877151 | 12587715 | Nasal disorder | |
| 125877151 | 12587715 | Nasal polypectomy | |
| 125877151 | 12587715 | Nasal polyps | |
| 125877151 | 12587715 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125877151 | 12587715 | 1 | 201601 | 0 | ||
| 125877151 | 12587715 | 2 | 201601 | 0 | ||
| 125877151 | 12587715 | 3 | 2012 | 0 | ||
| 125877151 | 12587715 | 8 | 2014 | 0 |